A new graphene-based brain-monitoring technology has helped scientists identify which areas of brain tissue are most vulnerable after an ischaemic stroke. Tested in mice, the sensors detected slow electrical waves linked to worsening injury and could eventually support more precise stroke treatment.
The international research involved Spain’s National Research Council (CSIC), the University of Manchester, the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and German company Multi Channel Systems. The findings were published in the scientific journal Brain.
How the graphene sensors detect damage after stroke
An ischaemic stroke occurs when a blockage interrupts blood flow to part of the brain. Although the initial injury happens quickly, damage can continue to spread through surrounding tissue.
One mechanism behind this progression is known as spreading cortical depolarisation. These waves of abnormal electrical activity travel through the brain and can place nearby tissue under additional stress.
Researchers have struggled to measure these signals accurately because they develop slowly and can be difficult for conventional recording equipment to capture. The new graphene sensors were designed to detect low-frequency electrical activity with greater sensitivity.
When placed on the brains of mice, the sensors recorded the electrical waves in detail. The characteristics of the signals enabled researchers to distinguish between:
- Relatively healthy brain tissue with recovery potential;
- Tissue that was vulnerable and at risk of further damage; and
- Areas that had already experienced severe injury.
Blood-flow responses could help predict further injury
The study also examined how brain blood flow responded to the electrical waves. In healthier areas, blood flow increased, potentially helping the tissue withstand the effects of the stroke.
In more vulnerable regions, however, blood flow could decrease instead. That response may deepen the injury by depriving already stressed tissue of additional oxygen and nutrients.
According to the researchers, the electrical signals could anticipate these different blood-flow responses. If the finding is confirmed in further research, this could provide a way to identify tissue that requires urgent protection before damage becomes irreversible.
Ketamine showed a possible protective effect in mice
The scientists also tested a low dose of ketamine in the animal models. The treatment reduced the length of the harmful electrical waves, improved the associated blood-flow response and limited the extent of brain damage observed in the mice.
These results suggest that ketamine may have a neuroprotective effect after stroke. However, the study does not establish that the drug offers the same benefit in people. The findings remain preclinical and would need to be assessed through additional laboratory work and, eventually, carefully designed human studies.
Ketamine is already used in medicine for several purposes, but its potential role in stroke care cannot be inferred from this mouse research alone. Questions about dosage, timing, safety and effectiveness would all require separate investigation.
Why the technology matters for future stroke treatment
The researchers say the main importance of the work lies in the ability to monitor brain activity at a level of detail that existing tools may not provide. Real-time information about changing brain tissue could help clinicians understand whether an area is recovering, deteriorating or responding to treatment.
In future, a technology of this kind could potentially support:
- More accurate identification of tissue at risk after a stroke;
- Closer monitoring of how brain injury develops over time;
- More targeted testing of neuroprotective medicines; and
- Personalised treatment decisions based on the condition of individual brain regions.
These possible uses are not yet available in routine healthcare. The sensors have so far been studied in mice, and their safety, practicality and performance in humans remain to be established.
International collaboration behind the research
The project builds on a long-running collaboration between research institutions in Spain and the United Kingdom focused on graphene devices for recording brain signals. Anton Guimerà-Brunet of CSIC’s Institute of Microelectronics of Barcelona said that measuring low-frequency brain activity remains a significant technical challenge.
University of Manchester researcher Rob Wykes said the work demonstrates how advanced measurement technologies can improve understanding of how brain lesions develop and how they might be treated. The researchers’ comments underline that the project is both a technology development and a biological investigation.
What happens next?
The next stage will be to determine whether the findings can be reproduced in other animal studies and whether the graphene sensors can be adapted for eventual clinical use. Researchers will also need to clarify how the detected signals relate to outcomes over longer periods.
Any move towards human trials would require evidence on device safety, surgical or clinical practicality, data reliability and patient benefit. The ketamine findings would likewise need independent assessment before the drug could be considered for a new role in stroke treatment.
For now, the research offers a promising way to study the hidden progression of stroke injury rather than a ready-to-use medical device or therapy.
Conclusion
The graphene sensors provide scientists with a clearer view of electrical activity and blood-flow changes in vulnerable brain tissue after stroke. While the research remains limited to mice, it could help guide future monitoring tools and treatments by showing where additional damage is most likely to occur. The immediate takeaway is that graphene-based brain sensing is a promising research platform, not yet an established treatment for stroke patients.
